Skip to main content
Erschienen in: Reactions Weekly 1/2022

01.10.2022 | Case report

Immunosuppressants/valganciclovir

Leukopenia and lack of efficacy: 2 case reports

Erschienen in: Reactions Weekly | Ausgabe 1/2022

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Schaenman J, et al. Early cytomegalovirus DNAemia and antiviral dose adjustment in high vs intermediate risk kidney transplant recipients. Transplant Infectious Disease 23: No. 1, Feb 2021. Available from: URL: http://doi.org/10.1111/tid.13457 Schaenman J, et al. Early cytomegalovirus DNAemia and antiviral dose adjustment in high vs intermediate risk kidney transplant recipients. Transplant Infectious Disease 23: No. 1, Feb 2021. Available from: URL: http://​doi.​org/​10.​1111/​tid.​13457
Metadaten
Titel
Immunosuppressants/valganciclovir
Leukopenia and lack of efficacy: 2 case reports
Publikationsdatum
01.10.2022
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2022
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-022-26572-0

Weitere Artikel der Ausgabe 1/2022

Reactions Weekly 1/2022 Zur Ausgabe

Case report

Multiple drugs

Case report

Multiple drugs

Case report

Oxcarbazepine